European Journal of Medicinal Chemistry
Publisher: Elsevier · ISSN 0223-5234 · 57 articles
- Small-Molecule Ligands of Epac Proteins: Tools for Studying Epac Signaling and Prospects for Drug Discovery
- Structure–Activity Relationships of C-2-Functionalized 4-Styrylquinoline Hybrids Reveal Divergent Effects of Styryl Halogenation on Antiproliferative and Antitrypanosomal Activity
- Progress and Challenges of KRAS Degraders
- Discovery of Novel Pyrrolo[2,3-d]pyrimidine Derivatives as Potent and Effective RSK4 Inhibitors for the Treatment of Esophageal Squamous Cell Carcinoma
- From single to dual targeting: Recent advances in EGFR-based dual inhibitors for cancer therapy
- Artificial intelligence in antiviral drug discovery: Data resources, methods, and applications
- Imidazopyridines as anticancer chemotypes: Structure-activity relationships, molecular targets, and lead optimization opportunities
- Reimagining natural products: Tools and approaches to create new chemical entities for drug discovery
- Ketohexokinase inhibitor discovery and clinical translation: Medicinal chemistry, tissue pharmacology, and biomarker-guided development
- Metal-organic frameworks for cancer drug delivery: Molecular design, therapeutic mechanisms, safety, and clinical translation
- Hydroxypyridinone scaffolds linking antimicrobial and anti-tyrosinase activity through metal chelation: An integrated medicinal chemistry review
- Chemical strategies for targeting colorectal cancer (CRC): From pathway nodes to small-molecule design
- Exploring emerging therapeutic opportunities of druggable enzyme targets involved in type 2 diabetes
- Indole-based anti-angiogenic agents via VEGFR-2 inhibition: A critical review
- Novel amidino-substituted phenylene-bis(benzazoles): Design, synthesis, biological evaluation and DNA binding properties
- Cancer-selective cytotoxicity of a semi-synthetic derivative of oleuropein via proteostasis network impairment
- H2S-activated NO-releasing theranostics for combined gas and photodynamic therapy against colorectal cancer
- Design, synthesis, and antitumor evaluation of novel VEGFR-2/BRD4 dual inhibitors with potent in vivo efficacy
- Design, synthesis, and biological evaluation of diosgenin derivatives containing arylsulfonamide moieties as anti-osteosarcoma agents through modulation of the Hippo pathway
- Discovery and pharmacological profiling of quinoline- and quinoxaline-based phenoxypropanoic acid derivatives as multitarget modulators of PPARα, FXR, and LXRα receptors
- Structure–signal relationships at κ-opioid receptor (KOR) revealed by bicyclo[2.2.2]octene enamide derivatives
- Design, synthesis and biological evaluation of pleiotropic prodrugs activated by cholinesterases and releasing a 5-HT4R agonist, with in vivo antiamnesic activity
- Half-sandwich Ir(III) and Rh(III) complexes bearing a π-extended pyrene-based N^N-ligand: Metal- and monodentate ligand influence on photodynamic therapy
- Silencing las and rhl quorum sensing systems in MDR Pseudomonas aeruginosa: Design, synthesis, biological evaluation and molecular modeling of novel quinolin-2-one derivatives
- Structure-activity relationship and target identification of marine anthranilamides as anti-inflammatory agents
- Design and synthesis of carvedilol-derived dual-functional adjuvant agents with oral activity against doxorubicin cardiotoxicity and anticancer efficacy
- Computationally driven design and validation of piperazine-bridged phthalimide derivatives as multifunctional agents against Alzheimer's disease
- HDAC3 degradation to uncover therapeutic vulnerability in colorectal cancer
- Discovery of 3-phenyldibenzo[b,d]furan derivatives as potent multi-stage inhibitors against SARS-CoV-2
- Divergently synthesis and antifibrotic evaluation of fucosylated chondroitin sulfate oligosaccharides with defined sulfation patterns